Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $841.07 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $161.77 | 7 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $160.22 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $93.37 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $35.74 | 2 | $0 (2017) |
| PFIZER INC. | $35.49 | 2 | $0 (2024) |
| Allergan Inc. | $31.87 | 2 | $0 (2017) |
| Arbor Pharmaceuticals, Inc. | $25.74 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.21 | 1 | $0 (2024) |
| Amgen Inc. | $22.18 | 2 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $21.26 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $532.60 | 24 | Alexion Pharmaceuticals, Inc. ($134.60) |
| 2023 | $66.40 | 3 | ABBVIE INC. ($40.78) |
| 2022 | $20.44 | 1 | ABBVIE INC. ($20.44) |
| 2018 | $19.28 | 1 | GlaxoSmithKline, LLC. ($19.28) |
| 2017 | $202.35 | 15 | Amarin Pharma Inc. ($35.74) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.21 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Rare Disease | ||||||
| 09/25/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: OSTEOPOROSIS | ||||||
| 09/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.08 | General |
| 09/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Neuropsychiatry | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: PAIN | ||||||
| 08/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Immunology | ||||||
| 07/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Neuropsychiatry | ||||||
| 06/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Rare Disease | ||||||
| 06/20/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Genetic Disease | ||||||
| 06/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Rare Disease | ||||||
| 04/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 04/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Neuropsychiatry | ||||||
| 02/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Neuropsychiatry | ||||||
| 11/29/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 6,823 | 11,409 | $927,607 | $487,174 |
| 2022 | 42 | 5,920 | 9,922 | $830,328 | $446,125 |
| 2021 | 40 | 4,717 | 8,769 | $775,446 | $421,672 |
| 2020 | 47 | 4,110 | 6,217 | $597,414 | $268,884 |
All Medicare Procedures & Services
179 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 435 | 2,794 | $243,643 | $185,178 | 76.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 723 | 1,253 | $273,154 | $105,502 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 259 | 259 | $60,865 | $32,440 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 281 | 323 | $48,450 | $20,520 | 42.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 205 | 372 | $24,241 | $18,135 | 74.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 303 | 387 | $23,388 | $14,598 | 62.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 193 | 373 | $18,072 | $13,660 | 75.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 207 | 424 | $18,496 | $12,740 | 68.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 64 | 64 | $22,208 | $10,337 | 46.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 360 | 430 | $20,640 | $7,078 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 365 | 462 | $17,556 | $6,041 | 34.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 340 | 340 | $12,580 | $6,000 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 461 | 688 | $9,632 | $5,779 | 60.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 421 | 547 | $16,410 | $5,661 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $17,034 | $4,748 | 27.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 263 | 263 | $9,468 | $4,637 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 34 | $9,996 | $4,337 | 43.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 419 | 552 | $12,144 | $4,202 | 34.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $6,720 | $3,219 | 47.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 19 | $6,992 | $3,006 | 43.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 135 | 135 | $6,887 | $2,554 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $6,315 | $2,316 | 36.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 70 | 76 | $6,156 | $2,183 | 35.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 115 | 180 | $5,040 | $1,714 | 34.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 132 | 155 | $3,875 | $1,364 | 35.2% |
About Dr. Daniel Johnson, MD
Dr. Daniel Johnson, MD is a Family Medicine healthcare provider based in Bradenton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740206549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Johnson, MD has received a total of $841.07 in payments from pharmaceutical and medical device companies, with $532.60 received in 2024. These payments were reported across 44 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($841.07).
As a Medicare-enrolled provider, Johnson has provided services to 21,570 Medicare beneficiaries, totaling 36,317 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 179 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bradenton, FL
- Active Since 07/14/2006
- Last Updated 10/18/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740206549
Products in Payments
- ULTOMIRIS (Biological) $160.22
- INGREZZA (Drug) $93.37
- QULIPTA (Drug) $71.32
- UBRELVY (Drug) $63.56
- Vascepa (Drug) $35.74
- CREON (Drug) $26.89
- Edarbyclor (Drug) $25.74
- HYQVIA (Biological) $25.21
- Prolia (Biological) $22.18
- OCALIVA (Drug) $21.26
- ELIQUIS (Drug) $20.64
- SHINGRIX (Biological) $19.28
- ZENPEP (Drug) $18.21
- TERIPARATIDE (Drug) $16.73
- ONPATTRO (Drug) $16.61
- BYSTOLIC (Drug) $16.32
- VOQUEZNA (Drug) $16.25
- VIBERZI (Drug) $15.55
- NURTEC ODT (Drug) $14.85
- MERLIN@HOME (Device) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bradenton
Dr. Jeremy Mcconnell, M.d, M.D
Family Medicine — Payments: $395,542
Dr. Azim Lalani, Md, MD
Family Medicine — Payments: $14,602
Ahmad Sahebzamani, Md, MD
Family Medicine — Payments: $12,480
Charles Timson, Md, MD
Family Medicine — Payments: $9,190
Dr. Drew Edwards, M.d, M.D
Family Medicine — Payments: $8,731
Dr. Audrey Lewerenz-Walsh, Do, DO
Family Medicine — Payments: $8,307